Frédéric Rolland
Institut de Cancérologie de l'Ouest(FR)Centre Hospitalier René-Dubos(FR)
Publications by Year
Research Areas
Renal cell carcinoma treatment, Head and Neck Cancer Studies, Cancer Immunotherapy and Biomarkers, Bladder and Urothelial Cancer Treatments, Cancer Genomics and Diagnostics
Most-Cited Works
- → Sorafenib in Advanced Clear-Cell Renal-Cell Carcinoma(2007)4,772 cited
- → Postoperative Irradiation with or without Concomitant Chemotherapy for Locally Advanced Head and Neck Cancer(2004)3,135 cited
- → Lenvatinib plus Pembrolizumab or Everolimus for Advanced Renal Cell Carcinoma(2021)1,691 cited
- → Pembrolizumab versus methotrexate, docetaxel, or cetuximab for recurrent or metastatic head-and-neck squamous cell carcinoma (KEYNOTE-040): a randomised, open-label, phase 3 study(2018)1,654 cited
- → Sorafenib for Treatment of Renal Cell Carcinoma: Final Efficacy and Safety Results of the Phase III Treatment Approaches in Renal Cancer Global Evaluation Trial(2009)1,079 cited
- → Open-Label, Uncontrolled, Multicenter Phase II Study to Evaluate the Efficacy and Toxicity of Cetuximab As a Single Agent in Patients With Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck Who Failed to Respond to Platinum-Based Therapy